Humulin R Kwikpen (Insulin Human)

Humulin R Kwikpen is indicated for the treatment of diabetes mellitus when rapid‑acting insulin is required. It is used as part of a comprehensive diabetes management plan that may include diet, exercise, and other medications.

• Type 1 diabetes mellitus requiring mealtime insulin coverage.
• Type 2 diabetes mellitus when basal insulin alone is insufficient.
• Supplemental insulin for correction of hyperglycemia.
• Use in insulin‑pump transition periods under medical supervision.
• Pediatric patients (≥6 years) as directed by a healthcare professional.

• Insulin human in Humulin R Kwikpen binds to insulin receptors on cell membranes, activating the receptor’s intrinsic tyrosine kinase activity. This triggers intracellular signaling cascades that promote glucose uptake in muscle and adipose tissue, stimulate glycogen synthesis in the liver, and suppress hepatic glucose production, thereby lowering circulating blood glucose concentrations.

Adverse reactions to Humulin R Kwikpen vary in frequency and severity.

Common

• Hypoglycemia (low blood glucose)
• Injection site redness, swelling, or itching
• Lipodystrophy at the injection site
• Mild weight gain
• Transient headache

Serious

• Severe hypoglycemia requiring assistance
• Allergic reactions such as urticaria or angioedema
• Anaphylaxis
• Persistent hyperglycemia due to insulin resistance
• Injection‑site infection.

Humulin R Kwikpen should be used with caution and under medical supervision.

• Verify blood glucose levels before each dose to avoid hypoglycemia.
• Adjust dose during illness, pregnancy, or changes in physical activity.
• Do not use if the pen has been dropped, exposed to extreme temperatures, or is past the expiration date.
• Monitor for signs of allergic reaction, especially after first use.
• Educate patients on proper injection technique and rotation of sites.
• Discuss with a healthcare provider before switching from other insulin formulations.

Certain medications and substances can affect the action of Humulin R Kwikpen.

Avoid

• Concurrent use of other rapid‑acting insulins without dose adjustment.
• High‑dose beta‑blockers that may mask hypoglycemia symptoms.
• Alcohol excess, which can potentiate insulin’s glucose‑lowering effect.

Use with caution

• Oral antidiabetic agents (e.g., sulfonylureas, meglitinides) that increase hypoglycemia risk.
• Thiazide diuretics, which may raise blood glucose levels.
• Corticosteroids, which can cause insulin resistance.
• Certain antihypertensives (e.g., ACE inhibitors) that may alter renal insulin clearance.